Search results: Sage Journals

Open accessResearch articleFirst published December, 2019

A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple Myeloma

Sabarinath V. Radhakrishnan, Michael Boyer, Catherine M. Sherwin [...]

Cell Transplantation

Restricted accessResearch articleFirst published 2025

Evaluation of hepatotoxicity due to conditioning regimens in beta thalassemia major and aplastic anemia patients undergoing bone marrow transplantation

Sadia Parveen, Muhammad Liaquat Raza, Saqib Hussain Ansari [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published June, 2018

Comparison of conditioning regimen toxicities among autologous stem cell transplantation eligible multiple myeloma patients: High-dose melphalan versus high-dose melphalan and bortezomib

Eda Aypar, Fikret Vehbi İzzettin, Şahika Zeynep Akı [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published 2021

Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma

Songyi Park, Dong-Yeop Shin, Junshik Hong [...]

Therapeutic Advances in Hematology

Open accessResearch articleFirst published 2025

Comparative efficacy and safety of modified BEAM and BEAM/BEAC as conditioning regimens for autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma

Xiao-Ning Wang, Yu-Qi Wang, Rui-Min Liu [...]

Cell Transplantation

Open accessResearch articleFirst published 2023

BeEAM (Bendamustine,Etoposide,Cytarabine,Melphalan) Versus BEAM (Carmustine,Etoposide,Cytarabine,Melphalan) as Conditioning Regimen Before Autologous Haematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis

Ran Wu, Liyuan Ma

Cell Transplantation

Open accessResearch articleFirst published 2025

Age- and comorbidity-adjusted busulfan,fludarabine,cytarabine,and low-dose TBI-based conditioning regimen is effective for myelodysplastic syndromes with excess blasts undergoing allogeneic peripheral blood stem cell transplantation

Jie Gao, Huixian Wu, Huiying Qiu [...]

Cell Transplantation

Open accessResearch articleFirst published 2026

Efficacy and safety of Busulfan–Fludarabine versus Busulfan–Cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplant in hematologic malignancy patients: a meta-analysis of randomized controlled trials and observational studies

Aizaz Ali, Muhammad Abdullah Ali, Abdullah Afridi [...]

Therapeutic Advances in Hematology

Restricted accessResearch articleFirst published December, 2014

Modeling Promising Nonmyeloablative Conditioning Regimens in Nonhuman Primates

Devikha Chandrasekaran, Betty Nakamoto, Korashon L. Watts [...]

Human Gene Therapy

Open accessResearch articleFirst published 2026

Efficacy and safety of mitoxantrone hydrochloride liposome/ thiotepa/ busulfan/fludarabine (MTBF) conditioning regimen for salvage allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory acute myeloid leukemia: A single - Arm prospective clinical trial

Juan Ren, Tongxin Zhang, Yuqi Wang [...]

Cell Transplantation

Open accessResearch articleFirst published December, 2019

A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple Myeloma

Sabarinath V. Radhakrishnan, Michael Boyer, Catherine M. Sherwin [...]

Cell Transplantation

Restricted accessResearch articleFirst published 2025

Evaluation of hepatotoxicity due to conditioning regimens in beta thalassemia major and aplastic anemia patients undergoing bone marrow transplantation

Sadia Parveen, Muhammad Liaquat Raza, Saqib Hussain Ansari [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published June, 2018

Comparison of conditioning regimen toxicities among autologous stem cell transplantation eligible multiple myeloma patients: High-dose melphalan versus high-dose melphalan and bortezomib

Eda Aypar, Fikret Vehbi İzzettin, Şahika Zeynep Akı [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published 2021

Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma

Songyi Park, Dong-Yeop Shin, Junshik Hong [...]

Therapeutic Advances in Hematology

Open accessResearch articleFirst published 2025

Comparative efficacy and safety of modified BEAM and BEAM/BEAC as conditioning regimens for autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma

Xiao-Ning Wang, Yu-Qi Wang, Rui-Min Liu [...]

Cell Transplantation

Open accessResearch articleFirst published 2023

BeEAM (Bendamustine,Etoposide,Cytarabine,Melphalan) Versus BEAM (Carmustine,Etoposide,Cytarabine,Melphalan) as Conditioning Regimen Before Autologous Haematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis

Ran Wu, Liyuan Ma

Cell Transplantation

Open accessResearch articleFirst published 2025

Age- and comorbidity-adjusted busulfan,fludarabine,cytarabine,and low-dose TBI-based conditioning regimen is effective for myelodysplastic syndromes with excess blasts undergoing allogeneic peripheral blood stem cell transplantation

Jie Gao, Huixian Wu, Huiying Qiu [...]

Cell Transplantation

Open accessResearch articleFirst published 2026

Efficacy and safety of Busulfan–Fludarabine versus Busulfan–Cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplant in hematologic malignancy patients: a meta-analysis of randomized controlled trials and observational studies

Aizaz Ali, Muhammad Abdullah Ali, Abdullah Afridi [...]

Therapeutic Advances in Hematology

Restricted accessResearch articleFirst published December, 2014

Modeling Promising Nonmyeloablative Conditioning Regimens in Nonhuman Primates

Devikha Chandrasekaran, Betty Nakamoto, Korashon L. Watts [...]

Human Gene Therapy

Open accessResearch articleFirst published 2026

Efficacy and safety of mitoxantrone hydrochloride liposome/ thiotepa/ busulfan/fludarabine (MTBF) conditioning regimen for salvage allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory acute myeloid leukemia: A single - Arm prospective clinical trial

Juan Ren, Tongxin Zhang, Yuqi Wang [...]

Cell Transplantation